{"name":"Centro Cardiologico Monzino","slug":"centro-cardiologico-monzino","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Furosemide and matched saline hydration","genericName":"Furosemide and matched saline hydration","slug":"furosemide-and-matched-saline-hydration","indication":"Acute decompensated heart failure with fluid overload","status":"phase_3"}]}],"pipeline":[{"name":"Furosemide and matched saline hydration","genericName":"Furosemide and matched saline hydration","slug":"furosemide-and-matched-saline-hydration","phase":"phase_3","mechanism":"Furosemide is a loop diuretic that inhibits sodium and chloride reabsorption in the ascending limb of the loop of Henle, promoting fluid excretion, while saline hydration provides intravenous fluid replacement to maintain hemodynamic stability.","indications":["Acute decompensated heart failure with fluid overload","Cardiorenal syndrome prevention during diuresis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBaRlpIanpnXzlBb0x4Z0ZmNUhrU29qVVdiWXFXcllXZFB2U2kxX2xWcEVKdEJ1dHU4T205UzVscTQ5cWFXRGI1VWhPc1B6Zy1wU254eFlKZ1BXVk00Y2lz?oc=5","date":"2023-12-13","type":"pipeline","source":"Nature","summary":"The translational gap: bridging basic research, clinical practices and society - Nature","headline":"The translational gap: bridging basic research, clinical practices and society","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNTnNOSmNQZElET2hTRURFeElaMnZ2N1lHTDhWVjIzRGVlVTVqQjZHc0hmS3BJdlVvdEFDWlJQZF9PVVpLY0pPX09qOERjTkk4cktsNGZjcGo1clZVd2xhdzhZVmEwSF8yNDJDRzZMNWJhZ0RldjBvb19sQWpvbXNyQTZNUzJ2UFcwS3NUSjZBdUVOVGlySmZDSExB?oc=5","date":"2020-07-28","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie helps autoimmune startup Enthera to €28M A round - Fierce Biotech","headline":"AbbVie helps autoimmune startup Enthera to €28M A round","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}